Wells Fargo & Company Talis Biomedical Corp Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.44 - $0.54 $3 - $3	7 Added 4.19%	174 $0
Q1 2023 May 12, 2023	BUY	$0.48 - $0.64 $1 - $1	3 Added 1.83%	167 $0
Q4 2022 Feb 13, 2023	BUY	$0.45 - $11.67 $2 - $58	5 Added 3.14%	164 $0
Q3 2022 Nov 14, 2022	BUY	$0.7 - $10.79 $37 - $582	54 Added 51.43%	159 $0
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.44 $2,403 - $4,272	-2,967 Reduced 96.58%	105 $0
Q1 2022 May 16, 2022	SELL	$1.3 - $4.19 $6,436 - $20,744	-4,951 Reduced 61.71%	3,072 $4,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.17 $30,567 - $49,501	8,023 New	8,023 $32,000
Q3 2021 Nov 15, 2021	SELL	$6.02 - $12.46 $117,733 - $243,680	-19,557 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.62 - $14.56 $148,330 - $224,500	15,419 Added 372.62%	19,557 $216,000
Q1 2021 May 13, 2021	BUY	$11.2 - $27.8 $46,345 - $115,036	4,138 New	4,138 $53,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.